BIOCON
Back to Cashflow Statement
|
BIOCON Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹13,049 Cr | ₹242 Cr | ₹2,564 Cr | ₹388 Cr | ₹-242 Cr |
What is the latest Cash Flow from Financing Activities ratio of BIOCON ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹13,049 Cr |
Mar2022 | ₹242 Cr |
Mar2021 | ₹2,564 Cr |
Mar2020 | ₹388 Cr |
Mar2019 | ₹-242 Cr |
How is Cash Flow from Financing Activities of BIOCON Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹13,049 Cr | 5,289.80 | |
Mar2022 | ₹242 Cr | -90.56 | |
Mar2021 | ₹2,564 Cr | 561.51 | |
Mar2020 | ₹388 Cr | Positive | |
Mar2019 | ₹-242 Cr | - |
Compare Cash Flow from Financing Activities of peers of BIOCON
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BIOCON | ₹35,849.9 Cr | 3.1% | 16.4% | 32.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,512.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics |
BIOCON Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BIOCON | 3.1% |
16.4% |
32.6% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses